MEDAXONE POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL
Product details
Registration number: SIN16288P
Classification: Prescription Only
Active ingredients: Ceftriaxone sodium equivalent to ceftriaxone
Strength: 2000.0mg
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.
ATC code: J01DD04
HSA approval date: 26 July 2021
Manufacturer(s):
- Medochemie (Far East) Ltd. (Aseptic Cephalosporin Facility)
- Medochemie Ltd ( Factory C)
Manufacturing country/countries: VIETNAM SOC REP OF; CYPRUS
What are the HSA registration number and classification for MEDAXONE POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16288P
Classification: Prescription Only
What active ingredients and strength are recorded for MEDAXONE POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Ceftriaxone sodium equivalent to ceftriaxone
Strength: 2000.0mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for MEDAXONE POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Who is the recorded registrant for MEDAXONE POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for MEDAXONE POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Medochemie (Far East) Ltd. (Aseptic Cephalosporin Facility)
- Medochemie Ltd ( Factory C)
Manufacturing country/countries: VIETNAM SOC REP OF; CYPRUS
Where can I look up MEDAXONE POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16288P or the exact product name MEDAXONE POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL. The general register link does not preselect this product.
What are the source dates for this MEDAXONE POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this MEDAXONE POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16288P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)